6-Bromo-3H-[1,2,3]triazolo[4,5-b]pyridine

Catalog No. :
ACRJCL602
CAS No. :
92276-38-5
Molecular Formula :
C5H3BrN4
Molecular Weight :
199.01

IUPAC Name:6-bromo-3H-[1,2,3]triazolo[4,5-b]pyridine

6-Bromo-3H-[1,2,3]triazolo[4,5-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$177.00Login to see priceIn stockInquiry
25g98%$612.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-3H-[1,2,3]triazolo[4,5-b]pyridine
IUPAC Name6-bromo-3H-[1,2,3]triazolo[4,5-b]pyridine
MDL No.MFCD04060716 | MFCD08703628
Molecular FormulaC5H3BrN4
Molecular Weight199.01
SMILESBrC1=CC2=C(NN=N2)N=C1
InChI KeyYKWWQNVTTSHHGH-UHFFFAOYSA-N
Synonym6-bromo-2H-triazolo[4,5-b]pyridine | DTXSID20238949 | F17474 | 8E4RMX4N4V | AM806780 | BDBM50591481 | (2S,4R)-4-hydroxy-2-hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester | 3H-Triazolo[4,5-b]pyridine,6-bromo- | A1-02009 | FT-0683611 | SCHEMBL7
CAS No.92276-38-5
PubChem CID494193

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACRJCL602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNPOX072 route compound structure diagram
    ACNPOX07238875-53-5 In Stock
  4. Then
  5. ACRJCL602 route product structure diagram
    ACRJCL60292276-38-5 In Stock
Inquiry

2. ACRJCL602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. ACNPOX072 route compound structure diagram
    ACNPOX07238875-53-5 In Stock
  4. Then
  5. ACRJCL602 route product structure diagram
    ACRJCL60292276-38-5 In Stock
Inquiry

Comments (0)